Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
EED-IN-5
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | EED-IN-5 is an orally active, EZH2-selective trisubstituted pyridine EED-H3K27me3 inhibitor and immunomodulator with anti-inflammatory properties. It targets EED with an IC50 of 28.21 nM. In mouse models, oral administration of EED-IN-5 leads to preferential and sustained accumulation in lymph nodes. This compound reduces H3K27me3 levels in dendritic cells and inhibits their migration, consequently decreasing the infiltration of specific dendritic cells, macrophages, and T cells into the spinal cord and brain. EED-IN-5 shows hERG inhibition activity, tests negative in Mini-Ames assays, and does not exhibit significant toxicity with long-term high-dose administration. EED-IN-5 is applicable for multiple sclerosis research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.